Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new drug to see if it's safe and effective at reducing levels of Lipoprotein(a) in the blood.
- Cardiovascular Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
To what extent has the Food and Drug Administration sanctioned AMG 890?
"The safety of AMG 890 has been estimated at a 1 due to this being an early-phase trial, with limited evidence attesting to its efficacy and safety."
What is the scope of this medical experiment in terms of number of hospitals?
"This medical trial has recruited 6 sites, including the University of Kansas Medical Center in Kansas City and Excel Medical Clinical Trials in Boca Raton. Additionally, QPS Miami Research Associates located in South Miami is a participant as well."
Is the age threshold for participation in this clinical trial greater than 60 years?
"According to the enrollment criteria of this medical investigation, those aged between 18 and 70 are eligible for participation."
What qualifications must an individual possess in order to be considered eligible for this trial?
"This medical study seeks 79 adult participants with cardiovascular disease and a BMI between 18-40 who have elevated plasma Lp(a) levels. Additionally, female volunteers must be of non-reproductive standing while other criteria may also apply."
Are there still openings for this experiment to be conducted on individuals?
"This trial, first published on July 30th 2018, is no longer recruiting participants according to clinicaltrials.gov. Nonetheless, 423 alternative scientific studies are currently seeking volunteers."
Share this study with friends
Copy Link
Messenger